Beyond Air Reports Financial Results for Fiscal Fourth Quarter and Year-End 2020

Jun 22, 2020 4:01pm EDT

Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors

Jun 22, 2020 9:00am EDT

Beyond Air Announces First Patient Enrolled in its U.S. Study of Nitric Oxide Therapy Using the LungFit™ System in COVID-19 Patients

Jun 15, 2020 8:30am EDT

Beyond Air Announces Publication of Peer-Reviewed Journal Article in Scientific Reports

Jun 15, 2020 8:00am EDT

Beyond Air™ Scheduled to Announce Fiscal Year 2020 Financial Results on Monday, June 22nd

Jun 08, 2020 5:29pm EDT

Beyond Air Receives Approval from Health Canada to Study Nitric Oxide Generated and Delivered by the LungFit™ in COVID-19 Patients

May 26, 2020 8:30am EDT

Beyond Air Achieves Primary Endpoint in Pilot Bronchiolitis Study

May 20, 2020 8:30am EDT

Beyond Air™ to Present New Data in an e-Poster Presentation at the Upcoming AACR Virtual Annual Meeting II on June 22nd to 24th

May 15, 2020 8:30am EDT

Beyond Air Enters into New Common Stock Purchase Agreement Extending Relationship with Lincoln Park Capital

May 15, 2020 8:25am EDT

Beyond Air to Initiate Clinical Study Evaluating High Concentration Nitric Oxide for the Treatment of COVID-19 Patients in the United States

Apr 16, 2020 8:30am EDT